Monthly Archives: June 2011

SciCafe: Snapshots of four Hot Boston Labs
June 16, 2011

A great group of four researchers shared updates on their lab’s recent findings at this morning’s SciCafe in Boston.   Cancer, autoimmunity, stem cells – lots of great science. For those that don’t know SciCafe, here’s the background: Nature Biotech’s

Leave a comment

SmartCells, Smart Story: Lean Biotech, Large Return
June 13, 2011

Todd Zion, the founder of the adjustable insulin company, SmartCells, has done wonders for the Boston Life Science angel community – and reinvigorated their interest in funding therapeutics companies.  It’s a great story and Todd deserves the attention he’s been

5 Comments

Contrave: Latest Casualty in the FDA’s War Against Obesity Drugs
June 9, 2011

Last week’s news about Orexigen’s Contrave obesity drug and its struggles with the FDA’s Division of Metabolic and Endocrinologic Products has left me puzzled.  Obesity is such an enormous epidemic, one has to wonder why the FDA is taking such

4 Comments

AVEO: An early stage VC perspective
June 2, 2011

I heard AVEO Pharmaceuticals’ CEO Tuan Ha-Ngoc speak at Convergence last month and decided AVEO would be a superb company to profile as a way to highlight the triad we all dream of in biotech venture investing: great science, great

5 Comments